Literature DB >> 27412415

Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses.

Mark Hatherill1, Thomas J Scriba1, Sara Suliman1, Hennie Geldenhuys1, John L Johnson2, Jane E Hughes1, Erica Smit1, Melissa Murphy1, Asma Toefy1, Lesedi Lerumo1, Christiaan Hopley1, Bernadette Pienaar1, Phalkun Chheng2, Elisa Nemes1, Daniel F Hoft3, Willem A Hanekom1, W Henry Boom2.   

Abstract

One third of the global population is estimated to be latently infected with Mycobacterium tuberculosis We performed a phase I randomized controlled trial of isoniazid preventive therapy (IPT) before revaccination with bacillus Calmette-Guérin (BCG) in healthy, tuberculin skin test-positive (≥15-mm induration), HIV-negative South African adults. We hypothesized that preclearance of latent bacilli with IPT modulates BCG immunogenicity following revaccination. Frequencies and coexpression of IFN-γ, TNF-α, IL-2, IL-17, and/or IL-22 in CD4 T cells and IFN-γ-expressing CD8 T, γδ T, CD3(+)CD56(+) NKT-like, and NK cells in response to BCG were measured using whole blood intracellular cytokine staining and flow cytometry. We analyzed 72 participants who were revaccinated with BCG after IPT (n = 33) or without prior IPT (n = 39). IPT had little effect on frequencies or cytokine coexpression patterns of M. tuberculosis- or BCG-specific responses. Revaccination transiently boosted BCG-specific Th1 cytokine-expressing CD4, CD8, and γδ T cells. Despite high frequencies of IFN-γ-expressing BCG-reactive CD3(+)CD56(+) NKT-like cells and CD3(-)CD56(dim) and CD3(-)CD56(hi) NK cells at baseline, BCG revaccination boosted these responses, which remained elevated up to 1 y after revaccination. Such BCG-reactive memory NK cells were induced by BCG vaccination in infants, whereas in vitro IFN-γ expression by NK cells upon BCG stimulation was dependent on IL-12 and IL-18. Our data suggest that isoniazid preclearance of M. tuberculosis bacilli has little effect on the magnitude, persistence, or functional attributes of lymphocyte responses boosted by BCG revaccination. Our study highlights the surprising durability of BCG-boosted memory NKT-like and NK cells expressing antimycobacterial effector molecules, which may be novel targets for tuberculosis vaccines.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27412415      PMCID: PMC4976036          DOI: 10.4049/jimmunol.1501996

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor.

Authors:  Elisa Montaldo; Chiara Vitale; Francesca Cottalasso; Romana Conte; Timor Glatzer; Paolo Ambrosini; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

2.  Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.

Authors:  B R Lauwerys; J C Renauld; F A Houssiau
Journal:  Cytokine       Date:  1999-11       Impact factor: 3.861

3.  Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

Authors:  Heinrich Schlums; Frank Cichocki; Bianca Tesi; Jakob Theorell; Vivien Beziat; Tim D Holmes; Hongya Han; Samuel C C Chiang; Bree Foley; Kristin Mattsson; Stella Larsson; Marie Schaffer; Karl-Johan Malmberg; Hans-Gustaf Ljunggren; Jeffrey S Miller; Yenan T Bryceson
Journal:  Immunity       Date:  2015-03-17       Impact factor: 31.745

4.  SPICE: exploration and analysis of post-cytometric complex multivariate datasets.

Authors:  Mario Roederer; Joshua L Nozzi; Martha C Nason
Journal:  Cytometry A       Date:  2011-01-07       Impact factor: 4.355

Review 5.  Isoniazid for preventing tuberculosis in non-HIV infected persons.

Authors:  M J Smieja; C A Marchetti; D J Cook; F M Smaill
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns.

Authors:  Benjamin M N Kagina; Brian Abel; Thomas J Scriba; Elizabeth J Hughes; Alana Keyser; Andreia Soares; Hoyam Gamieldien; Mzwandile Sidibana; Mark Hatherill; Sebastian Gelderbloem; Hassan Mahomed; Anthony Hawkridge; Gregory Hussey; Gilla Kaplan; Willem A Hanekom
Journal:  Am J Respir Crit Care Med       Date:  2010-06-17       Impact factor: 21.405

7.  Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.

Authors:  P R Wheeler; P M Anderson
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

8.  Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.

Authors:  Andreia P Soares; Thomas J Scriba; Sarah Joseph; Ryhor Harbacheuski; Rose Ann Murray; Sebastian J Gelderbloem; Anthony Hawkridge; Gregory D Hussey; Holden Maecker; Gilla Kaplan; Willem A Hanekom
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

9.  High frequencies of CD158b+ NK cells are associated with persistent hepatitis C virus infections.

Authors:  Hui-Fan Ji; Juan Wang; Lei Yu; Jun-Qi Niu; Desalegn Admassu Ayana; Yan-Fang Jiang
Journal:  Ann Hepatol       Date:  2013 Jul-Aug       Impact factor: 2.400

10.  BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control.

Authors:  Corinne S C Merle; Sergio S Cunha; Laura C Rodrigues
Journal:  Expert Rev Vaccines       Date:  2010-02       Impact factor: 5.217

View more
  57 in total

1.  Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and NK Cell Function.

Authors:  Helen R Wagstaffe; Harry Pickering; Joanna Houghton; Jason P Mooney; Asia-Sophia Wolf; Natalie Prevatt; Ron H Behrens; Martin J Holland; Eleanor M Riley; Martin R Goodier
Journal:  J Immunol       Date:  2019-08-19       Impact factor: 5.422

2.  Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth.

Authors:  Maria Papadopoulou; Tanya Dimova; Muki Shey; Libby Briel; Helen Veldtsman; Nondumiso Khomba; Hadn Africa; Marcia Steyn; Willem A Hanekom; Thomas J Scriba; Elisa Nemes; David Vermijlen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-14       Impact factor: 11.205

3.  Twist1 and Twist2 Induce Human Macrophage Memory upon Chronic Innate Receptor Treatment by HDAC-Mediated Deacetylation of Cytokine Promoters.

Authors:  Rui Sun; Matija Hedl; Clara Abraham
Journal:  J Immunol       Date:  2019-04-26       Impact factor: 5.422

Review 4.  Origins of natural killer cell memory: special creation or adaptive evolution.

Authors:  Kayla A Holder; Emilie M Comeau; Michael D Grant
Journal:  Immunology       Date:  2018-02-15       Impact factor: 7.397

5.  BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults.

Authors:  Srabanti Rakshit; Asma Ahmed; Vasista Adiga; Bharath K Sundararaj; Pravat Nalini Sahoo; John Kenneth; George D'Souza; Wesley Bonam; Christina Johnson; Kees Lmc Franken; Tom Hm Ottenhoff; Greg Finak; Raphael Gottardo; Kenneth D Stuart; Stephen C De Rosa; M Juliana McElrath; Annapurna Vyakarnam
Journal:  JCI Insight       Date:  2019-12-19

Review 6.  Redefining Memory: Building the Case for Adaptive NK Cells.

Authors:  Silke Paust; Catherine A Blish; R Keith Reeves
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

7.  Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.

Authors:  Joshua Ghofrani; Olivier Lucar; Haley Dugan; R Keith Reeves; Stephanie Jost
Journal:  Eur J Immunol       Date:  2019-05-02       Impact factor: 5.532

8.  Mycobacterium tuberculosis Transfer RNA Induces IL-12p70 via Synergistic Activation of Pattern Recognition Receptors within a Cell Network.

Authors:  Caroline Keegan; Stephan Krutzik; Mirjam Schenk; Philip O Scumpia; Jing Lu; Yan Ling Joy Pang; Brandon S Russell; Kok Seong Lim; Scarlet Shell; Erin Prestwich; Dan Su; David Elashoff; Robert M Hershberg; Barry R Bloom; John T Belisle; Sarah Fortune; Peter C Dedon; Matteo Pellegrini; Robert L Modlin
Journal:  J Immunol       Date:  2018-04-02       Impact factor: 5.422

Review 9.  Chronic Immune Activation in TB/HIV Co-infection.

Authors:  Riti Sharan; Allison N Bucşan; Shashank Ganatra; Mirko Paiardini; Mahesh Mohan; Smriti Mehra; Shabaana A Khader; Deepak Kaushal
Journal:  Trends Microbiol       Date:  2020-04-22       Impact factor: 17.079

Review 10.  Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Authors:  Suraj B Sable; James E Posey; Thomas J Scriba
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.